INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
SKIN
SUSTAINABILITY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
MEDIA PACK
CONTRIBUTE
Subscribe
INJECTION
DUAL CHAMBER
FORMULATION
PFS
WEARABLES
ALL INJECTION
OCULAR
ORAL
RESPIRATORY
PULMONARY
NASAL
ALL RESPIRATORY
SKIN
SUSTAINABILITY
MORE
INTERVIEWS
EXPERT VIEWS
EARLY INSIGHTS
COMPANY LISTINGS
OUR AUTHORS
THE MAGAZINE
EVENTS
ED CALENDAR
MEDIA PACK
CONTRIBUTE
SEARCH
SEARCH
advanced search
CONNECTIVITY
CONNECTIVITY
Bjarne Sørensen
Phillips Medisize
RE-USABLE ELECTRONIC AUTOINJECTOR – FLEXIBLE PERFORMANCE
Bjarne Sørensen discusses the ability of electronically driven injection devices to cater for a broad range of liquid drug properties within a single device platform.
INJECTION
Jimmy Fan
CC Bio
I-PLATFORM DEVICE: THE SMART DEVICE WITH APTITUDE
Jimmy Fan outlines the capabilities and benefits of the I-Platform smart drug delivery device.
CONNECTIVITY
Arnaud Guillet
Biocorp
INJAY: SIMPLE BY CHOICE, ADAPTABLE BY DESIGN
Arnaud Guillet discusses Biocorp’s Injay solution for adding connectivity to a wide variety of PFS devices, focusing on how Injay’s designed-in simplicity and flexibility makes it easily applicable across the spectrum of PFS platforms on the market today.
CONNECTIVITY
Mauro Citterio
RS01X – BERRY GLOBAL HEALTHCARE’S SINGLE-DOSE DPI GOES DIGITAL WITH AMIKO’S RESPIRO
Mauro Citterio, Director, Marco Franza and Martijn Grinovero discuss Berry and Amiko’s partnership to develop the RS01X connected single-dose dry powder inhaler, based on Berry’s commercialised RS01 inhaler and Amiko’s Respiro digital health platform.
EXPERT VIEW
George I’ons
CONNECTED DRUG DELIVERY: ACHIEVING OPTIMAL BENEFITS THROUGH SMART COLLABORATION
George I’ons discusses the challenges developing connected devices presents to key market stakeholders when it comes to successful rollout and implementation. Additionally, he considers the perspectives of these market players, as well as the patients themselves, with respect to how connected drug delivery devices can help them to better achieve their desired outcomes.
CONNECTIVITY
Mr Michael Kiely
Jabil Healthcare
MEDICAL DEVICE DESIGN STRATEGY FOR A CONNECTED FUTURE
Michael Kiely, Laura Marsden, Peter Stringer, and David Boyle discuss the design challenges at the electromechanical interface and encourage manufacturers to adopt a standardised approach for connecting medical devices to the cloud.
CONNECTIVITY
Neil Williams
Phillips Medisize
THE CHANGING FACE OF CONNECTED HEALTH IN THE TIME OF COVID-19
Neil Williams and Angela R Eder both of Phillips-Medisize, discuss how the current pandemic is transforming the adoption of connected health.
CONNECTIVITY
Arnaud Guillet
Biocorp
MALLYA: ENLIGHTENING PAST, EXCITING PRESENT, PROMISING FUTURE
Arnaud Guillet reviews the Mallya connected device platform, from the origins of the project to the current success in diabetes and deployment in other fields, and introduces the promising next-generation Mallya.
CONNECTIVITY
Marcus Bates
Aptar Pharma
THE COVID-19 CATALYST: HOW A GLOBAL PANDEMIC IS ACCELERATING THE NEED FOR DIGITAL HEALTH
Marcus Bates discusses the positive impact covid-19 has had on the digital health industry, including the acceleration and development of remote patient services.
CONNECTIVITY
Edgar Hernan Cuevas Brun
HCmed Innovations
IMPROVING INHALATION THERAPY ADHERENCE WITH CONNECTED DEVICES
Edgar Hernan Cuevas Brun discusses the role of connectivity in improving adherence to medication and introduces the company’s mesh nebuliser smart cap, Pulmogine+.
CONNECTIVITY
Dr Fred Metzmann
Haselmeier
D-FLEX
®
ECOSYSTEM – FROM DATA TO VALUE
Fred Metzmann and Frank Leipold discuss the benefits of connected medical devices in clinical trials and describe the advantages of Haselmeier's D-Flex
®
Ecosystem for improving adherence and reducing the dropout rate in clinical trials.
PULMONARY
Edgar Hernan Cuevas Brun
HCmed Innovations
AN INTRODUCTION TO SMART BREATH-ACTUATED NEBULISERS
Edgar Hernan Cuevas Brun considers the benefits of smart breath-actuated nebulisers and looks at the latest technology contributing to the evolution of nebulisers.
INJECTION
Dr Iain Simpson
Phillips Medisize
THE NEW EMERGING NEEDS DRIVING AUTOINJECTOR DEVELOPMENT
Iain Simpson discusses the emerging needs to be considered when bringing new autoinjector drug-device combinations to market.
CONNECTIVITY
Arnaud Guillet
Biocorp
MEASURING & MANAGING MEDICATION ADHERENCE FROM CLINICAL TRIALS TO ROUTINE CARE: INJAY MEMS AS
®
Arnaud Guillet and Bernard Vrijens discuss the issue of medication non-adherence in both clinical trials and commercialised drug products, and how Biocorp’s Injay connected prefilled syringe solution combined with Aardex’s MEMS Adherence Software provides a solution.
CONNECTIVITY
Sheila Trgovac
HOW DIGITAL TECHNOLOGY CAN TRANSFORM CLINICAL TRIALS
Sheila Trgovac and Rebecca Ford suggest that now is the time for innovation in clinical trials – using a patient-centric approach whilst leveraging digital solutions to create a digital clinical trial ecosystem.
WEARABLES
Tony Bedford
Phillips Medisize
EMERGING TRENDS IN WEARABLE DRUG DELIVERY
Tony Bedford discusses the current state of the fledgling on-body injector market, including the difficulties of competing with autoinjectors in the <5 mL space, the potential on-body injectors have in oncology and Phillips-Medisize’s own developments in the on-body injector field.
EXPERT VIEW
Napoleon Monroe
COVID-19: A CATALYST FOR IMPLEMENTING CONNECTED HEALTHCARE PRODUCTS?
Napoleon Monroe analyses how covid-19 is catalysing a wide range of reactions in healthcare, explaining how drug and device connectivity are essential to improving patient access to treatment – and patient outcomes – as well as reducing overall cost.
CONNECTIVITY
John Merhige
Credence MedSystems
THE AWARD-WINNING CREDENCE CONNECT™ AUTO-SENSING INJECTION SYSTEM
John Merhige explains how connectivity that is universally applicable to any existing prefilled syringe platform adds value throughout the ecosystem, both including and beyond the “compliance business model”.
CONNECTIVITY
Marnik Vaes
POLYMERIC EMI SHIELDING: PROVIDING A MORE SECURE FUTURE FOR PATIENTS
Marnik Vaes, Leen-Pieter Deurloo and Martin Sas discuss the role of polymeric electromagnetic interference shielding in providing a more secure future for patients in a connected world.
CONNECTIVITY
Gaël Senée
Biocorp
SENSORS ARE TOOLS – BUT HOW DO YOU MAKE THEM SMART?
Gaël Senée and Arnaud Guillet explore the benefits of Mallya – a smart sensor that turns conventional injection pens into connected devices. They also discuss the crucial role Biocorp’s connected prefilled syringe, Injay, could play in future COVID-19 vaccination programmes.
EXPERT VIEW
Tom Oakley
RISKS AND REAL-WORLD SOLUTIONS FOR CONNECTED MEDICAL DEVICES
Tom Oakley discusses the risks surrounding the use of connected drug delivery devices – and the real-world solutions that have either been proved or are being trialled.
CONNECTIVITY
Erin Miller
Noble
APPLYING CONNECTIVITY TO ENHANCE THE TRAINING STANDARD OF CARE FOR SELF-INJECTION
Erin Miller looks at how connectivity can be used to enhance training to help address the challenges of accuracy and non-adherence when patients self-inject their medications.
CONNECTIVITY
Chelsea Williams
SHL Medical
DIGITAL HEALTH REFORMULATION: FROM HOPE TO HYPE TO HEALTH
Chelsea Williams, Ramin Rafiei and Ralph Howald discuss the accelerating value of digital health to improve the patient experience, achieve improved health outcomes, and increase health system efficiency and value.
INTERVIEW
Sai Shankar
Aptar Pharma
INTERVIEW WITH SAI SHANKAR, ADAM SHAIN & MARCUS BATES
Sai Shankar, Adam Shain and Marcus Bates discuss the full potential of connectivity, coronavirus as a potential accelerator of adoption, and the place of connected drug delivery systems within Aptar Pharma’s broader offering to industry.
Prev
1
…
4
5
6
7
8
…
14
Next
Top
